Master every high-yield pathology topic for NEET PG 2027: cell injury, inflammation, neoplasia, hematopathology, immunopathology, genetic disorders, and systemic pathology with tumor markers, staining patterns, and diagnostic criteria.
NEETPGAI EditorialReviewed by SME AgentPublished 19 Nov 2025Updated 29 Sept 202634 min read
Share this article
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Ready to put this into practice?
Start practicing NEET PG MCQs with AI-powered explanations.
Pathology contributes 18–24 questions to NEET PG — the highest-weighted preclinical subject after Anatomy. Focus on these 8 high-yield areas:
Cell injury and adaptation — five types of necrosis (coagulative, liquefactive, caseous, fat, fibrinoid) with classic examples; apoptosis vs necrosis distinguishing features; reversible vs irreversible cell injury
Inflammation and repair — acute vs chronic inflammation mediators; granulomatous diseases and their causative organisms; wound healing phases; keloid vs hypertrophic scar
Neoplasia — tumor markers by organ system; grading vs staging principles; paraneoplastic syndromes and their associated tumors; oncogenes and tumor suppressor genes
Hematopathology — anemia classification by MCV with confirmatory lab findings; ALL vs AML vs CLL vs CML comparison; Hodgkin vs non-Hodgkin lymphoma differentiation; Reed-Sternberg cell variants
Immunopathology — Types I–IV hypersensitivity with mechanism and prototype disease; autoimmune disease antibody-disease associations; transplant rejection types
Laboratory investigations and staining patterns — special stains and their targets; IHC markers for tumor identification; electron microscopy findings for glomerulonephritis
This guide covers each area with the histological facts, classification tables, and diagnostic criteria that NBE tests — structured so you can retain them under exam pressure.
Pathology is the foundation of clinical medicine. Every diagnosis in every clinical subject rests on pathological principles — the mechanism of cell death determines the clinical picture, the histological pattern identifies the tumor, and the immunological mechanism predicts the treatment. Unlike subjects where memorization alone can carry you through, Pathology rewards conceptual understanding: a student who grasps why coagulative necrosis preserves architecture will never confuse it with liquefactive necrosis, regardless of how the question is phrased.
That conceptual foundation, paired with systematic table-based revision, is what converts Pathology from a feared subject into a reliable source of marks. Use the Pathology subject hub alongside this guide for daily MCQ practice, and apply spaced repetition to the tables in this article using the method described in our spaced repetition guide.
Cell injury and adaptation: the foundation of all pathology
Cell injury is the alteration of normal cellular structure and function that occurs when a cell is exposed to stress beyond its adaptive capacity — and it is the conceptual anchor for every other topic in pathology. Understanding why cells die and how they die determines the clinical manifestations that Medicine and Surgery questions then test.
Reversible vs irreversible cell injury
Reversible injury (cell can recover if stress is removed): cellular swelling (earliest change), fatty change, blebbing of plasma membrane, clumping of chromatin. Earliest light microscopy change is cellular swelling (hydropic change). Earliest ultrastructural changes include ER dilation, ribosomal detachment, and mitochondrial swelling.
Irreversible injury (cell death is inevitable): loss of plasma membrane integrity, massive calcium influx, mitochondrial permeability transition, nuclear changes (pyknosis → karyorrhexis → karyolysis). The point of no return is severe mitochondrial dysfunction combined with plasma membrane damage.
Types of necrosis — the most tested pathology table
Type
Mechanism
Gross appearance
Microscopy
Classic examples
Coagulative
Ischemia (except brain)
Firm, pale, wedge-shaped
Ghost outlines of cells preserved; no nuclei
MI, renal infarct, splenic infarct
Liquefactive
Bacterial infection OR brain ischemia
Liquid, pus-filled cavity
Cell architecture completely dissolved
Brain infarct, lung abscess, bacterial abscesses
Caseous
Granulomatous infection
Cheese-like, crumbly white
Amorphous granular debris; no cell outlines; surrounded by granuloma
Tuberculosis (pathognomonic), histoplasmosis
Fat
Lipase activation
Chalky white deposits (saponification)
Fat cells with shadowy outlines; calcium soap deposits
Acute pancreatitis, traumatic fat necrosis of breast
NBE examination pattern: Questions present a clinical scenario — a patient with a cortical brain lesion that is fluid-filled, or a pancreatic mass with chalky deposits — and ask for the type of necrosis. Lock the brain-liquefactive and TB-caseous associations as primary recall items.
Key NBE fact: Councilman bodies in viral hepatitis and Civatte bodies in lichen planus are examples of apoptosis — not necrosis. Apoptosis in the liver produces acidophilic (eosinophilic) bodies.
Cellular adaptations
Hypertrophy (increased cell size, no division): cardiac hypertrophy in hypertension — myocardial cells cannot divide, so they enlarge. Hyperplasia (increased cell number): endometrial hyperplasia in estrogen excess — cells CAN divide. Atrophy (reduced cell size): disuse atrophy, denervation atrophy. Metaplasia (one adult cell type to another): Barrett esophagus (squamous → columnar, intestinal type), bronchial squamous metaplasia in smokers. Dysplasia (disordered growth): pre-neoplastic; reversible if stimulus removed.
Inflammation and repair: mediators, granulomas, and wound healing
Inflammation is the vascular and cellular response of living tissue to injury, infection, or foreign material — and it is the mechanism that links pathology to every clinical manifestation of disease. NBE tests inflammation through mediator identification, granuloma cause recognition, and wound healing sequencing.
Complement C3a, C5a: anaphylatoxins (mast cell degranulation); C5a also a potent neutrophil chemoattractant
Granulomatous inflammation — causes by organism and disease
A granuloma is a focal area of chronic granulomatous inflammation characterized by aggregates of activated macrophages (epithelioid cells), often with multinucleated giant cells, lymphocytes, and a variable degree of central necrosis.
Cause
Type of granuloma
Giant cell type
Necrosis
Distinguishing feature
Tuberculosis
Caseous granuloma
Langhans giant cells
Caseous central necrosis
AFB on ZN stain; PCR for M. tuberculosis
Sarcoidosis
Non-caseating granuloma
Langhans or foreign body
NO necrosis
Schaumann bodies, asteroid bodies; ACE elevated
Leprosy
Granulomatous (tuberculoid) or diffuse (lepromatous)
Virchow cells in lepromatous
None
AFB within macrophages (lepromatous)
Crohn disease
Non-caseating granuloma
Foreign body type
None
Transmural; skip lesions
Cat scratch disease
Stellate granuloma with central suppuration
Rare
Suppurative
Bartonella henselae; warthin-starry stain
Fungal (Histoplasma, Coccidioides)
Caseating or non-caseating
Langhans or foreign body
Variable
Silver stain for fungal elements
Foreign body reaction
Foreign body granuloma
Foreign body giant cells
None
Polarizable material within giant cells
Berylliosis
Non-caseating granuloma
Langhans
None
Mimics sarcoidosis; occupational history
NBE trap: Sarcoidosis granulomas are non-caseating — the ABSENCE of necrosis distinguishes them from TB. A question presenting bilateral hilar lymphadenopathy + non-caseating granulomas on biopsy = sarcoidosis.
Neoplasia: tumor markers, grading, and paraneoplastic syndromes
Neoplasia is the abnormal proliferation of cells that have escaped normal regulatory controls — and it is the single highest-yield pathology area for NEET PG, contributing 6–8 questions per paper. The testable core is concentrated in tumor markers, grading vs staging principles, paraneoplastic syndromes, and molecular oncology.
Tumor markers — the complete NBE table
Tumor marker
Associated tumor
Clinical use
Key fact
AFP (Alpha-fetoprotein)
Hepatocellular carcinoma, yolk sac tumor (testis)
Screening in cirrhosis, monitoring treatment response
Normal in adults; physiologically elevated in pregnancy and fetal life
PSA (Prostate-specific antigen)
Prostate carcinoma
Screening, monitoring
Elevated in BPH and prostatitis — not cancer-specific
CEA (Carcinoembryonic antigen)
Colorectal carcinoma (primary); also GI, lung, breast
Monitoring recurrence after resection
Not useful for screening; re-elevated CEA after resection = recurrence
Should be undetectable after total thyroidectomy; rising = recurrence
S-100
Melanoma, schwannoma, S-100+ histiocytoses
IHC marker for neural crest origin
Not secreted into blood; tissue IHC marker
Chromogranin A
Neuroendocrine tumors (carcinoid, pheochromocytoma, small cell lung)
Serum marker for NET; IHC marker
Useful for carcinoid syndrome follow-up
PLAP (Placental alkaline phosphatase)
Grading vs staging — principles tested by NBE
Grading is a histological assessment of tumor differentiation (how much the tumor resembles normal tissue). It assesses the PRIMARY tumor.
Grade
Differentiation
Mitoses
Architecture
Grade I (well-differentiated)
Closely resembles normal tissue
Few
Near-normal gland/structure formation
Grade II (moderately differentiated)
Moderate resemblance
Moderate
Partially preserved architecture
Grade III (poorly differentiated)
Little resemblance
Many
Architecture largely lost
Grade IV (anaplastic/undifferentiated)
No resemblance
Numerous, atypical
No recognizable pattern
Staging uses TNM: Tumor size/extension (T), Nodal involvement (N), Metastasis (M). Staging determines prognosis more reliably than grading for most tumors. Critical NBE point: For prognosis, staging outweighs grading. A well-differentiated (Grade I) tumor that has metastasized (Stage IV) has worse prognosis than a poorly differentiated (Grade III) localized tumor (Stage I).
Paraneoplastic syndromes are clinical effects of malignancy that are not due to direct tumor invasion, obstruction, or metastasis — they are mediated by hormones, peptides, or antibodies produced by the tumor.
Small cell lung carcinoma, bronchial carcinoid, pancreatic NET
Ectopic ACTH
Ectopic ACTH: NO suppression even with high-dose dexamethasone (unlike pituitary Cushing disease which IS suppressed by high-dose). Rapid hypokalemic alkalosis, hyperpigmentation, muscle wasting — often WITHOUT classic cushingoid features.
Hypercalcemia
Squamous cell carcinoma of lung, breast, RCC, myeloma
PTHrP (PTH-related protein) or osteolytic metastases
Most common metabolic complication of malignancy
Lambert-Eaton myasthenic syndrome
Small cell lung carcinoma
Anti-VGCC antibodies
Proximal muscle weakness IMPROVES with repeated movement (opposite to MG)
Fasting hypoglycemia; serum C-peptide low in IGF-2 cases
Most tested NBE association: Small cell lung carcinoma causes SIADH, ectopic Cushing, and Lambert-Eaton — a single tumor type behind three distinct paraneoplastic syndromes.
Hematopathology: anemias, leukemias, and lymphomas
Hematopathology is the study of diseases of the blood, bone marrow, and lymphoid organs — contributing 5–7 questions per NEET PG with anemia classification, leukemia differentiation, and lymphoma histology as the primary targets.
Anemia classification by MCV
Category
MCV
Causes
Distinguishing lab
Microcytic (<80 fL)
Low
Iron deficiency anemia, beta-thalassemia trait, anemia of chronic disease, sideroblastic anemia
Serum ferritin (low in IDA, normal/high in others); HbA2 >3.5% in beta-thal
Induction: 7+3 (cytarabine + daunorubicin); AML-M3 (APL): ATRA + ATO
Watch-and-wait or ibrutinib/venetoclax
Imatinib (TKI) — dramatically changed natural history
Prognosis
>85% cure in children; worse in adults
30–40% long-term remission
Indolent, median survival 10+ years
Excellent with TKI; blast crisis = poor
Critical NBE distinguisher: Auer rods are pathognomonic for AML (especially AML-M3/APL). If the question mentions Auer rods, the answer is AML, and if it mentions disseminated intravascular coagulation in a leukemia patient, the answer is AML-M3 (APL) treated with ATRA.
Reed-Sternberg cell: Large binucleate or multinucleate cell with prominent eosinophilic "owl eye" nucleoli. CD15+ and CD30+ (with rare exception of nodular lymphocyte-predominant HL). Origin: germinal center B-cell that has lost normal B-cell markers.
Hodgkin vs Non-Hodgkin lymphoma:
Feature
Hodgkin lymphoma
Non-Hodgkin lymphoma
Spread
Contiguous node groups
Non-contiguous; skip areas
Extranodal
Rare
Common
Bone marrow
Rarely involved
Commonly involved
Mediastinal mass
Common (especially nodular sclerosis)
Variable
B symptoms
Classic (fever, night sweats, weight loss)
Variable
Treatment
ABVD chemotherapy ± radiotherapy
Depends on type (RCHOP for diffuse large B-cell)
Prognosis
Generally excellent (80%+ cure overall)
Variable by histological subtype
Immunopathology: hypersensitivity and autoimmune diseases
Immunopathology is the study of diseases caused by disordered immune responses — contributing 3–5 questions per NEET PG, with the four types of hypersensitivity reactions and autoimmune antibody associations as the most reliably tested areas.
Hypersensitivity reactions — Types I to IV
Type
Mechanism
Mediator
Onset
Prototype diseases
Type I (Immediate/Anaphylactic)
IgE bound to mast cells; allergen cross-links IgE → degranulation
Histamine, leukotrienes, prostaglandins
Minutes
Anaphylaxis, atopic asthma, hay fever, urticaria, food allergy
Type II (Antibody-mediated/Cytotoxic)
IgG or IgM binds to cell surface antigen; complement activation or ADCC
NBE examination pattern: The question presents a clinical scenario with a time course and asks for the hypersensitivity type. The time course is the key clue: immediate (minutes) = Type I; hours with tissue damage = Type II (or Type III if complement low); 48–72 hours = Type IV. An indurated PPD test read at 48–72 hours is always Type IV.
Autoimmune disease antibody associations
Disease
Key antibodies
Clinical significance
SLE
Anti-dsDNA (highly specific, correlates with activity), Anti-Smith (highly specific), ANA (sensitive, not specific), Anti-histone (drug-induced lupus)
Highly specific; granulomatous destruction of bile ducts
Autoimmune hepatitis
Anti-smooth muscle (ASMA), ANA (Type 1); Anti-LKM1 (Type 2)
AST/ALT-driven hepatitis; hypergammaglobulinemia
Goodpasture syndrome
Anti-GBM (anti-type IV collagen, alpha-3 chain)
Pulmonary hemorrhage + rapidly progressive GN
Wegener/GPA
c-ANCA (anti-PR3)
Upper + lower respiratory tract + renal triad
Microscopic polyangiitis
p-ANCA (anti-MPO)
Renal-predominant; pauci-immune GN
Transplant rejection types
Type
Timing
Mechanism
Histology
Treatment
Hyperacute
Minutes to hours after transplant
Preformed antibodies (Type II hypersensitivity)
Thrombosis, ischemic necrosis
Irreversible; must remove graft
Acute cellular
Days to months
CD8+ T-cell mediated; CD4+ T-cell mediated
Lymphocytic infiltration of parenchyma
Reversible with immunosuppression (pulse steroids)
Acute humoral (vascular)
Days to months
Donor-specific antibodies (DSA); C4d deposition
Vasculitis, C4d+ on peritubular capillaries
Plasmapheresis + IVIG
Chronic
Months to years
Both T-cell and antibody-mediated
Vascular intimal thickening, fibrosis, parenchymal loss
Largely irreversible; slow progression to graft failure
Genetic disorders: chromosomal and single-gene diseases
Genetic disorders are diseases caused by abnormalities in the genome — contributing 2–4 questions per NEET PG, with chromosomal disorder karyotypes and single-gene disorder inheritance patterns as the primary test targets.
Chromosomal disorders — karyotypes and clinical features
Disorder
Karyotype
Incidence
Cardinal features
NBE-tested fact
Down syndrome (Trisomy 21)
47, XX or XY, +21 (95%); Robertsonian translocation (4%); mosaic (1%)
1:700 live births
Flat face, epicanthal folds, upward slanting palpebral fissures, Brushfield spots, simian crease, duodenal atresia, AV septal defect, Alzheimer disease early
Maternal age most important risk factor; risk increases after 35
Systemic pathology is the application of general pathological principles to specific organ systems — and NBE tests it through clinicopathological correlations where the histological finding leads to the diagnosis.
No change (may see wavy fibers on electron microscopy)
4–12 hours
Pallor begins
Coagulation necrosis begins; contraction bands
12–24 hours
Pallor established
Pyknosis, beginning neutrophil infiltration
1–3 days
Hyperemia at borders
Neutrophil infiltration peak
3–7 days
Yellow-brown central softening
Macrophage infiltration; beginning phagocytosis
1–3 weeks
Yellow-white center, red vascular border
Granulation tissue, neovascularization
Months
White scar
Dense fibrous scar (collagen I)
Complications by timing: Day 1–3: arrhythmia (most common cause of death). Day 2–4: early fibrinous pericarditis (local inflammation from transmural necrosis). Day 3–7: rupture (free wall, septum, papillary muscle). 2–10 weeks post-MI: Dressler syndrome (autoimmune pericarditis — distinct from early pericarditis; caused by autoantibodies against myocardial antigens). Weeks to months: ventricular aneurysm.
Pulmonary pathology
Lung cancer types — histological differentiation:
Type
Location
Histology
Association
Paraneoplastic
Squamous cell carcinoma
Central/hilar
Keratin pearls, intercellular bridges
Smoking; Pancoast tumor
Hypercalcemia (PTHrP)
Adenocarcinoma
Peripheral subpleural
Glands, mucin production; Clara cells
Nonsmokers, women; EGFR mutations
Hypertrophic osteoarthropathy
Small cell (oat cell)
Central
Small cells with scant cytoplasm, nuclear molding; neuroendocrine markers
Smoking; very aggressive; early metastasis
SIADH, ectopic ACTH, Lambert-Eaton
Large cell carcinoma
Peripheral
No squamous, glandular, or small cell features; diagnosis of exclusion
Smoking
Variable
Bronchioloalveolar (now lepidic adenocarcinoma)
Peripheral
Tumor cells grow along alveolar walls (lepidic growth); no stromal invasion
Non-smokers; EGFR, ALK mutations
None
Hepatic pathology
Liver cirrhosis causes and histological patterns: Macronodular cirrhosis (nodules >3mm): viral hepatitis B and C, Wilson disease, hemochromatosis. Micronodular cirrhosis (nodules <3mm): alcoholic liver disease, biliary cirrhosis, hemochromatosis (early). Mixed: any cause at late stage.
Wilson disease vs hemochromatosis — NBE differentiator:
Feature
Wilson disease
Hemochromatosis
Metal
Copper (ATP7B mutation)
Iron (HFE gene, C282Y mutation)
Inheritance
Autosomal recessive
Autosomal recessive
Age of presentation
Young adults (5–35 years)
Middle-aged adults
Liver
Cirrhosis, acute liver failure
Cirrhosis
Other organs
Kayser-Fleischer rings (copper in Descemet membrane); neuropsychiatric; hemolysis
Adults; frontal lobe; 1p/19q co-deletion = good prognosis
Laboratory investigations and staining patterns: special stains and IHC markers
Laboratory pathology is the application of histochemical and immunohistochemical techniques to identify specific tissue components — and NBE consistently tests 2–3 questions on special stain-target associations and IHC marker-tumor associations.
Special stains — comprehensive table
Stain
Target/Substance
Colour
Diagnostic use
Hematoxylin and eosin (H&E)
Nuclei (blue), cytoplasm/collagen (pink)
Blue + pink
Routine tissue examination — used for all primary diagnosis
Study strategy: converting pathology knowledge into exam marks
Study strategy for pathology is the systematic approach to converting a mechanistically rich subject into reliable MCQ performance — and it differs from clinical subjects because Pathology is tested through histological descriptions, morphological associations, and classification tables rather than clinical decision-making.
The 3-phase approach for pathology
Phase 1 — Conceptual foundation (2 weeks). Study one chapter per day using Robbins Basic Pathology or an equivalent PG prep guide. For each topic, build a one-page table: the general pathway (mechanism) + the classic histological finding + the NBE-tested association. Do not memorize isolated facts — understand why coagulative necrosis preserves ghost outlines (early protein denaturation inactivates enzymes) and every necrosis question becomes solvable by logic.
Phase 2 — Table-based high-yield revision (1 week). Extract and drill only the tables from this guide: the five necrosis types, the four hypersensitivity mechanisms, the tumor markers table, the leukemia comparison, and the special stains table. Solve 30 pathology MCQs daily — 15 from a question bank and 15 from previous NEET PG papers. Categorize errors: morphology error, mechanism error, or classification error. Each error type needs a different revision strategy.
Phase 3 — Integration and rapid revision (3–4 days before exam). On each day, revise one table under timed conditions (5 minutes per table without looking at notes). On the final day, review: Auer rods = AML, Reed-Sternberg cell = Hodgkin lymphoma, Congo red + apple-green birefringence = amyloid, Philadelphia chromosome = CML, p53 mutation = most common genetic alteration in human cancers. These are the guaranteed 1-mark items.
For integration with clinical subjects, read our Surgery high-yield guide — surgical pathology (TNM staging, histological criteria for malignancy, wound healing) directly overlaps with pathology content tested in both papers. Apply the spaced repetition method to build a pathology flashcard deck — tables for necrosis types, tumor markers, and staining patterns are ideal spaced repetition material because they contain discrete, high-value facts.
Sources and references
Robbins and Cotran Pathologic Basis of Disease, 10th Edition (Kumar, Abbas, Aster, 2021) — the canonical reference for NEET PG Pathology; all mechanisms and morphological descriptions in this guide are based on Robbins.
Robbins Basic Pathology, 10th Edition (Kumar, Abbas, Aster, 2018) — concise version recommended for primary PG exam preparation.
Harsh Mohan's Textbook of Pathology, 8th Edition (2019) — widely used Indian pathology reference aligned with NMC curriculum; strong on Indian-context epidemiology.
WHO Classification of Tumours (5th Edition Blue Books, 2022) — organ-specific tumor classifications, grading criteria, and IHC marker standards.
WHO Classification of Haematolymphoid Tumours, 5th Edition (2022) — current classification of leukemias and lymphomas including updated genetic criteria.
Harrison's Principles of Internal Medicine, 21st Edition (Loscalzo et al., 2022) — source for paraneoplastic syndromes and systemic pathology clinicopathological correlations.
Frequently asked questions
How many pathology questions appear in NEET PG?
Pathology contributes 18–24 questions to NEET PG, making it one of the highest-weighted preclinical subjects. Neoplasia, hematopathology, and cell injury are the three most reliably tested areas, collectively accounting for 10–14 questions most years. Focused preparation on these areas yields the highest return.
Which pathology topics are tested most frequently in NEET PG?
Tumor markers, types of necrosis, leukemia differentiation (ALL/AML/CLL/CML), hypersensitivity reactions (Types I–IV), anemia classification by MCV, special staining patterns, and chromosomal disorder karyotypes dominate consistently across recent papers. Granulomatous inflammation causes and paraneoplastic syndromes also appear every year.
Should I read Robbins cover-to-cover for NEET PG pathology?
No. Robbins is the gold standard for understanding mechanisms, but reading it cover-to-cover is not the most efficient exam strategy. Use the concise version (Robbins Basic Pathology or a standard PG prep guide) to build concept maps, then drill MCQs. Reserve detailed Robbins chapters for neoplasia and hematopathology where mechanism depth directly translates to marks.
How do I remember all the tumor markers for NEET PG?
Organize tumor markers as tables by organ system rather than memorizing them as isolated facts. Associate each marker with a clinical scenario: AFP + hepatocellular carcinoma in a patient with cirrhosis; PSA + prostate nodule in an older man; CA-125 + pelvic mass in a woman. The vignette context triggers marker recall faster than rote memorization.
What is the best way to learn hypersensitivity reactions for NEET PG?
Learn the four types with one anchor disease each — Type I: anaphylaxis; Type II: Goodpasture syndrome; Type III: post-streptococcal glomerulonephritis; Type IV: contact dermatitis. Then expand to secondary examples for each type. The mechanism (IgE, antibody, immune complex, T-cell) is always the tested differentiator, not the disease name alone.
How do I differentiate ALL, AML, CLL, and CML for NEET PG?
Build a comparison table with five rows: age, cell type, cytochemistry marker, cytogenetic marker, and treatment. ALL: children, TdT+, Philadelphia chromosome in 20–25% of adult cases; AML: adults, MPO+, Auer rods; CLL: elderly, CD5+ CD23+ smudge cells, indolent; CML: middle-aged, BCR-ABL Philadelphia chromosome, imatinib. Practice the table until each column comes automatically.
How should I approach genetic disorders in pathology preparation?
Focus on karyotypes and cardinal clinical features for chromosomal disorders (Down 47+21, Turner 45X, Klinefelter 47XXY, Edwards 47+18, Patau 47+13). For single-gene disorders, learn the inheritance pattern and one pathognomonic feature per disease. Chromosomal banding patterns and FISH probes are high-yield for 1–2 image-based questions per paper.
What is the single most effective last-minute pathology revision strategy?
In the final two weeks, revise four tables daily: tumor markers by organ, necrosis types with examples, hypersensitivity mechanisms with diseases, and special stains with targets. Solve 30 pathology MCQs under timed conditions daily. On the final day, review only Auer rods, Philadelphia chromosome, Reed-Sternberg cells, and the five types of necrosis — these appear in nearly every paper.
Start your pathology prep today. Open the Pathology subject page and solve your first 15 MCQs — the morphological patterns you drill now are the patterns you will recognize on exam day.
See our pricing plans for unlimited practice across all 19 subjects.
Written by: NEETPGAI Editorial Team
Reviewed by: Dr. SME Agent, NEETPGAI Medical Advisory Board
Last reviewed: April 2026
This article is reviewed by qualified medical professionals for clinical accuracy and exam relevance. For corrections or updates, contact the editorial team.
Seminoma
IHC marker
Distinguishes seminoma from embryonal carcinoma
Silver (Bielschowsky, Bodian)
Axons, neurofibrils, reticulin
Black
CNS axonal pathology, reticulin fibre pattern in liver tumors
